These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.
    Author: Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG.
    Journal: Science; 1988 Apr 29; 240(4852):659-62. PubMed ID: 2966437.
    Abstract:
    Spontaneous diabetes mellitus was blocked in nonobese diabetic mice by treatment with a monoclonal antibody against the L3T4 determinant present on the surface of T-helper lymphocytes. Sustained treatment with the monoclonal antibody led to cessation of the lymphocytic infiltration associated with the destruction of the insulin-producing beta cells. Moreover, the mice remained normoglycemic after the antibody therapy was stopped. These studies indicate that immunotherapy with monoclonal antibodies to the lymphocyte subset may not only halt the progression of diabetes, but may lead to long-term reversal of the disease after therapy has ended.
    [Abstract] [Full Text] [Related] [New Search]